IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 96 filers reported holding IMMUNOMEDICS INC in Q4 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $17,092,000 | +4421.7% | 201,011 | +1785.1% | 0.46% | +4045.5% |
| Q2 2020 | $378,000 | -65.5% | 10,663 | -85.8% | 0.01% | -68.6% |
| Q1 2018 | $1,096,000 | -28.6% | 75,000 | -21.1% | 0.04% | -12.5% |
| Q4 2017 | $1,536,000 | +9.9% | 95,000 | -5.0% | 0.04% | -23.1% |
| Q3 2017 | $1,398,000 | +58.3% | 100,000 | 0.0% | 0.05% | +40.5% |
| Q2 2017 | $883,000 | +24.0% | 100,000 | -9.1% | 0.04% | +32.1% |
| Q1 2017 | $712,000 | +76.2% | 110,000 | 0.0% | 0.03% | +40.0% |
| Q4 2016 | $404,000 | +61.6% | 110,000 | +42.9% | 0.02% | +33.3% |
| Q3 2016 | $250,000 | +47.9% | 77,000 | +5.6% | 0.02% | +15.4% |
| Q2 2016 | $169,000 | -15.5% | 72,900 | -8.9% | 0.01% | +44.4% |
| Q1 2016 | $200,000 | -34.9% | 80,000 | -20.0% | 0.01% | -57.1% |
| Q4 2015 | $307,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
| Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
| Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
| Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
| Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
| NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
| RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
| DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
| Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
| DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |